Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Interest Income Over TimeStrong
Percentile Rank100
3Y CAGR+142.1%
5Y CAGR+101.4%
Year-over-Year Change
Income earned from interest-bearing assets
3Y CAGR
+142.1%/yr
Annual compound
5Y CAGR
+101.4%/yr
Recent acceleration
Percentile
P100
Near historical high
vs 5Y Ago
33.2x
Strong expansion
Streak
4 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $16.01M | +7.5% |
| 2024 | $14.89M | +24.4% |
| 2023 | $11.97M | +960.0% |
| 2022 | $1.13M | +5031.8% |
| 2021 | $22000.00 | -95.4% |
| 2020 | $483000.00 | -16.4% |
| 2019 | $578000.00 | - |
| 2018 | $0.00 | - |
| 2017 | $0.00 | - |